Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence

(E-pub Ahead of Print)

Author(s): Katerina Baou*, Vasiliki Katsi, Thomas Makris, Dimitris Tousoulis

Journal Name: Current Hypertension Reviews

Become EABM
Become Reviewer
Call for Editor


Approximately, half a century has passed since the discovery of beta blockers. Then, their prime therapeutic purpose was to treat angina and cardiac arrhythmias, nowadays, beta blockers’ usage and effectiveness is extended to treat other cardiovascular diseases, such as hypertension, congestive heart failure, and coronary artery disease. Safety concerns were raised about beta blockers and their use for chronic obstructive pulmonary disease (COPD) patients with concurrent cardiovascular disease. After a thorough research of the literature, this review summarizes the evidence proving that beta blockers not only might be well tolerated in COPD patients, but they might also have a beneficial effect in this group of patients.

Keywords: Beta-blockers, chronic obstructive pulmonary disease, exacerbations COPD, exacerbations cardiovascular disease, heart failure, lung function

Rights & PermissionsPrintExport Cite as

Article Details

Published on: 09 December, 2020
(E-pub Ahead of Print)
DOI: 10.2174/1573402116999201209203250
Price: $95

Article Metrics

PDF: 137